This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), to Integrated DNA Technologies, Inc. (IDT) for the supply of twelve (12) antisense oligonucleotides (ASOs) for an in-vivo neurotoxicity study. The contract has a ceiling value of $11,940.00 and a period of performance through March 26, 2026. This purchase order does not have a set-aside designation. IDT is a leading provider of specialized nucleic acid products and services to the U.S. federal government, supporting a wide range of federal agencies through both prime contracts and subcontracts. The company has significant federal contract vehicles, including a $100 million Blanket Purchase Agreement with the NIH and a $2.5 million Federal Supply Schedule contract with the Department of Veterans Affairs, which cover the delivery of various biological, oligonucleotide synthesis, and related laboratory supplies and services.
Generated 3/28/25, 10:55 AM